NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsAuthors' objectives
To critically review and assess the literature on the performance of magnetic resonance imaging (MRI) as a diagnostic test for primary breast cancer detection in patients with suspicious breast lesions, and to use this information to examine the cost-effectiveness of pre-operative MRI.
Searching
MEDLINE was searched from 1966 to August 1997 using an appropriate search strategy, which was presented in the review. The bibliographies of the references retrieved were manually searched for additional articles and suggestions from experts in the field were compiled. The search was limited to English language articles only.
Study selection
Study designs of evaluations included in the review
Studies were excluded if they did not present original research, or if they were published only as abstracts. Studies whose primary purpose was other than the evaluation of MRI for the detection of primary breast cancer (e.g. imaging of breast cancer in non-breast organs, silicone implants, recurrent breast cancer, or description of new biopsy or imaging protocols) were also excluded. Studies were also excluded from the meta-analysis if they: used an inadequate or non-standard definition of test results; used a non-standard diagnostic test; failed to account for all patients; contained fewer than 20 patients; selected atypical patients; had more than 15% of patients not included or were lost to follow-up.
Specific interventions included in the review
Studies of MRI were included. No detailed inclusion criteria relating to the index test were specified. All studies included in the meta-analysis used contrast-enhanced MRI.
Reference standard test against which the new test was compared
No inclusion criteria relating to the reference standard were specified. The included studies used histopathologic confirmation as the reference standard.
Participants included in the review
No inclusion criteria relating to the study participants were specified. The included studies were in female patients with suspicious breast lesions (palpable or non-palpable) referred for MRI. The patients included in the review were aged between 19 and 89 years. The lesion to patient ratio for the study populations included in the review ranged from 1.0 to 1.48. Studies that selected atypical patients were excluded from the review.
Outcomes assessed in the review
The included studies were required to report sufficient data for the construction of 2x2 contingency tables. The calculated outcome measures used by the review were sensitivity, specificity and prevalence.
How were decisions on the relevance of primary studies made?
Two investigators independently examined all the titles, abstracts and complete articles to select studies for detailed abstraction. Any disagreements were resolved by consensus.
Assessment of study quality
Studies selected for consideration were assessed according to a 10-point subjective quality score scale. Two investigators independently performed the quality assessment. Any disagreements were resolved by consensus.
Data extraction
The data were abstracted from each selected study by using a prospectively designed worksheet, which was presented in the review. Two investigators independently performed the data extraction and any disagreements were resolved by consensus. The categories of data extracted were: patient characteristics, technical factors, and method/validity with mean quality score. Technical factors included ear of publication, high field strength, gadolinium dose of 0.1 mmol/kg, enhancement criteria used for interpretation, and morphological criteria used for interpretation.
Methods of synthesis
How were the studies combined?
A summary receiver operating characteristic (sROC) curve was estimated using the method of Littenberg and Moses (see Other Publications of Related Interest no.1), and Q*, the point of maximal joint sensitivity and specificity on the sROC curve was calculated. The diagnostic odds ratio (OR) for positive breast MRI was also reported.
How were differences between studies investigated?
The threshold effect was investigated using the linear regression method of Littenberg and Moses (see Other Publications of Related Interest no.1) to assess the symmetry of the sROC curve.
Results of the review
A total of 41 (or possibly 37 - there is some ambiguity in the article) studies were subjected to further review and data extraction. Of these, 16 were included in the meta-analysis. The number of patients included in the review was not stated. The reasons for excluding 25 studies were also not given in the review.
The regression analysis showed a slope (b) of -0.21 (95% confidence interval, CI: -0.71, 0.28) and a p-value of 0.37. This indicated approximate symmetry of the summary ROC curve with an intercept (I) of 4.15 (95% CI: 3.06, 5.23). The pooled diagnostic OR for positive breast MRI was 63.1 (95% CI: 21.3, 186.8). The maximal joint sensitivity and specificity of the summary ROC curve was 0.89 (95% CI: 0.82, 0.93). At a sensitivity of 95%, the specificity was 67%.
The data from the 25 excluded studies were summarised. Where data to calculate sensitivity and specificity were available, these were found not to be statistically significantly different from those from the included studies. The year of publication, median reported prevalence of breast cancer, proportion in which sensitivity and specificity were calculable, and the mean quality score (worse) were statistically significantly different between the two groups of studies.
Cost information
The results from the sROC analysis were applied to a prior cost-effectiveness analysis (see Other Publications of Related Interest no.2). The cost-effectiveness of pre-operative MRI relative to that of excisional biopsy was confirmed, but its cost-effectiveness relative to that of needle core biopsy varied widely.
Authors' conclusions
For MRI to be a cost-effective alternative to excisional biopsy for the diagnosis of suspicious breast lesions, its diagnostic test performance must be equal to, or better than the best results in recently published studies.
CRD commentary
The review addressed an appropriate question, although the inclusion and exclusion criteria were not clearly stated in the review. The inclusion of studies in the meta-analysis appeared to depend upon components of quality and validity, although the exact criteria for exclusion were not clear. The literature search was limited to a single electronic database, although it was supplemented by hand checking of bibliographies and consultations with experts. Some important studies may have been missed, particularly as no non-English articles were considered, there was no attempt to identify unpublished literature, and studies published in abstract form only were specifically excluded. The validity of the studies included in the review was formally evaluated; although the details of the quality scale used were not clear, the report discussed verification bias and blinding. Details of the individual primary studies included in the meta-analysis were reported in the review, whereas details of the remaining studies were reported only as summary data. The meta-analysis performed was generally appropriate and well conducted. An additional formal evaluation of heterogeneity in studies included in the meta-analysis, beyond investigation of sROC symmetry, would have been useful. The authors' conclusions are supported by the data presented in the review.
Implications of the review for practice and research
Practice: If the accuracy of MRI, as achieved in the best clinical studies, can be validated, the use of MRI as a pre-operative test in women referred for excisional biopsy could result in a substantial decrease in the number of such referrals.
Research: A multi-institutional study is warranted to validate the accuracy of MRI in clinical practice.
Funding
U.S. National Institutes of Health, grant numbers RO1-CA58358-04 and RO1-CA70362; U.S. Army, grant number RP950855; American Heart Association Student Research Fellowship.
Bibliographic details
Hrung J M, Sonnad S S, Schwartz J S, Langlotz C P. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Academic Radiology 1999; 6(7): 387-397. [PubMed: 10410164]
Other publications of related interest
1. Littenberg B, Moses L. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993;13:313-21. 2. Hrung JM, Langlotz CP, Orel SG, Fox KR, Schnall MD, Schwartz JS. Cost-effectiveness of magnetic resonance imaging and needle core biopsy in the workup of suspicious breast lesions. Radiology 1997;205:538-9.
Indexing Status
Subject indexing assigned by NLM
MeSH
Adult; Aged; Aged, 80 and over; Breast /pathology; Breast Neoplasms /diagnosis /epidemiology; Cost-Benefit Analysis; Female; Humans; Magnetic Resonance Imaging; Middle Aged; ROC Curve; Sensitivity and Specificity
AccessionNumber
Database entry date
30/11/2003
Record Status
This is a critical abstract of a systematic review that meets the criteria for inclusion on DARE. Each critical abstract contains a brief summary of the review methods, results and conclusions followed by a detailed critical assessment on the reliability of the review and the conclusions drawn.
- Authors' objectives
- Searching
- Study selection
- Assessment of study quality
- Data extraction
- Methods of synthesis
- Results of the review
- Cost information
- Authors' conclusions
- CRD commentary
- Implications of the review for practice and research
- Funding
- Bibliographic details
- Other publications of related interest
- Indexing Status
- MeSH
- AccessionNumber
- Database entry date
- Record Status
- Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions.[Radiology. 1999]Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions.Hrung JM, Langlotz CP, Orel SG, Fox KR, Schnall MD, Schwartz JS. Radiology. 1999 Oct; 213(1):39-49.
- Meta-analysis of MR imaging in the diagnosis of breast lesions.[Radiology. 2008]Meta-analysis of MR imaging in the diagnosis of breast lesions.Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Radiology. 2008 Jan; 246(1):116-24. Epub 2007 Nov 16.
- Review Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis.[Radiology. 2014]Review Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis.Spick C, Baltzer PA. Radiology. 2014 Nov; 273(2):401-9. Epub 2014 Aug 11.
- Review Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis.[Breast Cancer Res Treat. 2011]Review Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis.Medeiros LR, Duarte CS, Rosa DD, Edelweiss MI, Edelweiss M, Silva FR, Winnnikow EP, Simões Pires PD, Rosa MI. Breast Cancer Res Treat. 2011 Apr; 126(2):273-85. Epub 2011 Jan 8.
- Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.[AJR Am J Roentgenol. 1997]Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.Nunes LW, Schnall MD, Siegelman ES, Langlotz CP, Orel SG, Sullivan D, Muenz LA, Reynolds CA, Torosian MH. AJR Am J Roentgenol. 1997 Aug; 169(2):409-15.
- Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic...Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...